Jennifer E. Cook - Net Worth and Insider Trading
Jennifer E. Cook Net Worth
The estimated net worth of Jennifer E. Cook is at least $1 Million dollars as of 2024-10-04. Jennifer E. Cook is the Director of Jazz Pharmaceuticals PLC and owns about 6,888 shares of Jazz Pharmaceuticals PLC (JAZZ) stock worth over $747,899. Jennifer E. Cook is also the Director of Denali Therapeutics Inc and owns about 20,038 shares of Denali Therapeutics Inc (DNLI) stock worth over $565,472. Details can be seen in Jennifer E. Cook's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jennifer E. Cook has not made any transactions after 2024-06-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jennifer E. Cook
Jennifer E. Cook Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jennifer E. Cook owns 3 companies in total, including Denali Therapeutics Inc (DNLI) , BridgeBio Pharma Inc (BBIO) , and Jazz Pharmaceuticals PLC (JAZZ) .
Click here to see the complete history of Jennifer E. Cook’s form 4 insider trades.
Insider Ownership Summary of Jennifer E. Cook
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DNLI | Denali Therapeutics Inc | 2024-06-06 | director |
| BBIO | BridgeBio Pharma Inc | 2019-12-12 | director |
| JAZZ | Jazz Pharmaceuticals PLC | 2023-12-04 | director |
Jennifer E. Cook Latest Holdings Summary
Jennifer E. Cook currently owns a total of 2 stocks. Among these stocks, Jennifer E. Cook owns 6,888 shares of Jazz Pharmaceuticals PLC (JAZZ) as of December 4, 2023, with a value of $747,899 and a weighting of 56.94%. Jennifer E. Cook also owns 20,038 shares of Denali Therapeutics Inc (DNLI) as of June 6, 2024, with a value of $565,472 and a weighting of 43.06%.
Latest Holdings of Jennifer E. Cook
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals PLC | 2023-12-04 | 6,888 | 108.58 | 747,899 |
| DNLI | Denali Therapeutics Inc | 2024-06-06 | 20,038 | 28.22 | 565,472 |
Holding Weightings of Jennifer E. Cook
Jennifer E. Cook Form 4 Trading Tracker
According to the SEC Form 4 filings, Jennifer E. Cook has made a total of 5 transactions in Jazz Pharmaceuticals PLC (JAZZ) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Jazz Pharmaceuticals PLC is the sale of 417 shares on December 4, 2023, which brought Jennifer E. Cook around $49,736.
According to the SEC Form 4 filings, Jennifer E. Cook has made a total of 1 transactions in Denali Therapeutics Inc (DNLI) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Denali Therapeutics Inc is the sale of 1,458 shares on June 6, 2024, which brought Jennifer E. Cook around $31,682.
Insider Trading History of Jennifer E. Cook
- 1
Jennifer E. Cook Trading Performance
Jennifer E. Cook Ownership Network
Jennifer E. Cook Owned Company Details
What does Denali Therapeutics Inc do?
Who are the key executives at Denali Therapeutics Inc?
Jennifer E. Cook is the director of Denali Therapeutics Inc. Other key executives at Denali Therapeutics Inc include CFO and Treasurer Steve E. Krognes , COO and Secretary Alexander O. Schuth , and Chief Medical Officer Carole Ho .
Denali Therapeutics Inc (DNLI) Insider Trades Summary
Over the past 18 months, Jennifer E. Cook made 1 insider transaction in Denali Therapeutics Inc (DNLI) with a net sale of 1,458. Other recent insider transactions involving Denali Therapeutics Inc (DNLI) include a net sale of 25,506 shares made by Vicki L Sato , a net sale of 93,768 shares made by Alexander O. Schuth , and a net sale of 54,249 shares made by Carole Ho .
In summary, during the past 3 months, insiders sold 73,507 shares of Denali Therapeutics Inc (DNLI) in total and bought 0 shares, with a net sale of 73,507 shares. During the past 18 months, 454,258 shares of Denali Therapeutics Inc (DNLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 454,258 shares.
Denali Therapeutics Inc (DNLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Denali Therapeutics Inc Insider Transactions
Jennifer E. Cook Mailing Address
Above is the net worth, insider trading, and ownership report for Jennifer E. Cook. You might contact Jennifer E. Cook via mailing address: C/o Denali Therapeutics Inc., 151 Oyster Point Blvd., 2nd Floor, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
